336 related articles for article (PubMed ID: 9174596)
1. Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells.
Park W; Weyand CM; Schmidt D; Goronzy JJ
Eur J Immunol; 1997 May; 27(5):1082-90. PubMed ID: 9174596
[TBL] [Abstract][Full Text] [Related]
2. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
3. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
de Waal Malefyt R; Yssel H; de Vries JE
J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
[TBL] [Abstract][Full Text] [Related]
4. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
Mukherjee S; Ahmed A; Nandi D
J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+ T cells.
Wolthers KC; Otto SA; Lens SM; Kolbach DN; van Lier RA; Miedema F; Meyaard L
Eur J Immunol; 1996 Aug; 26(8):1700-6. PubMed ID: 8765009
[TBL] [Abstract][Full Text] [Related]
6. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
[TBL] [Abstract][Full Text] [Related]
7. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
[TBL] [Abstract][Full Text] [Related]
8. Failure of correlation between B7 expression and activation of interleukin-2-secreting T cells.
Lombardi G; Sidhu S; Dodi T; Batchelor R; Lechler R
Eur J Immunol; 1994 Mar; 24(3):523-30. PubMed ID: 7510233
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-7 is a potent co-stimulus of the adhesion pathway involving CD2 and CD28 molecules.
Costello R; Brailly H; Mallet F; Mawas C; Olive D
Immunology; 1993 Nov; 80(3):451-7. PubMed ID: 7904590
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
11. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
[TBL] [Abstract][Full Text] [Related]
12. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
13. Requirements for stimulation or anergy induction in alloreactive human T cell clones.
Pawelec G; Kalbacher H; Pohla H; Boshell M; Max H; Friccius H; Adibzadeh M; Hambrecht A; Sansom D
Cell Immunol; 1994 Oct; 158(1):241-52. PubMed ID: 7522128
[TBL] [Abstract][Full Text] [Related]
14. Role of IL-6, IL-1, and CD28 signaling in responses of mouse CD4+ T cells to immobilized anti-TCR monoclonal antibody.
Holsti MA; McArthur J; Allison JP; Raulet DH
J Immunol; 1994 Feb; 152(4):1618-28. PubMed ID: 7907103
[TBL] [Abstract][Full Text] [Related]
15. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
16. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
17. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA
Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325
[TBL] [Abstract][Full Text] [Related]
18. Cell surface CD28 levels define four CD4+ T cell subsets: abnormal expression in rheumatoid arthritis.
Salazar-Fontana LI; Sanz E; Mérida I; Zea A; Sanchez-Atrio A; Villa L; Martínez-A C; de la Hera A; Alvarez-Mon M
Clin Immunol; 2001 May; 99(2):253-65. PubMed ID: 11318597
[TBL] [Abstract][Full Text] [Related]
19. Evidence for intact CD28 signaling in T cell hyporesponsiveness induced by the HIV-1 nef gene.
Collette Y; Mawas C; Olive D
Eur J Immunol; 1996 Aug; 26(8):1788-93. PubMed ID: 8765022
[TBL] [Abstract][Full Text] [Related]
20. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
